n increasing number of patients with rheumatoid arthritis (RA) are using cannabis to treat their symptoms, although systematic studies regarding efficacy in RA are lacking. Within this review we will give an overview on the overall effects of cannabinoids in inflammation and why they might be useful in the treatment of RA.
Minnesota’s medical cannabis program is unique, in that it routinely collects patient-reported scores on symptoms. This article focuses on changes in symptom severity reported by patients with cancer during their first 4 months of program participation.
Lots of people are using medical marijuana to treat their arthritis and other muscle aches and pains, often without consulting their doctor, a new study reports.
Patients in Northern Virginia can register now for Virginia’s medical cannabis program. We are Dalitso LLC dba Beyond/Hello, the medical cannabis processor that will serve patients across Northern Virginia.
A baby boy, born in a Norwich hospital in March, has become the first baby to take part in a medical cannabis trial. The trial will assess whether cannabis-derived medications could reduce the risk of brain injury following seizures.
The Jamaican government recently announced that it will be allowing medical marijuana patients to make cannabis purchases online for pickup at “herb houses” as a means to combat the coronavirus pandemic.
Materia has now acquired the licensed medical cannabis distributor, Cannaktiv, and has officially entered the German medical cannabis market.
Louisiana House Approves Medical Marijuana For Any Debilitating Condition, Along With Delivery Services
The Louisiana House of Representatives overwhelmingly approved bills on Friday to significantly expand the state’s medical cannabis program by bringing in patients with more conditions and allowing dispensaries to deliver marijuana products directly to those patients’ homes.
Despite a 2018 schedule change allowing prescribing of medical cannabis, patients are still faced with multiple barriers, including misinformation, stigma, and financial constraints, preventing access to potentially life-changing medicine.
As patients with painful terminal diseases may face unbearable pain, there is a need for more potent analgesics.